Any process that stops, prevents, or reduces the frequency, rate or extent of EGF-activated receptor activity.

The directed movement of a border cell through the nurse cells to reach the oocyte. An example of this is found in Drosophila melanogaster.

The process whose specific outcome is the progression of the haltere over time, from its formation to the mature structure. The haltere is the club-shaped 'balancers' found on each side of the metathorax among the true flies (Diptera). They are the much-modified hind wings.

The memory process that deals with the storage, retrieval and modification of information a long time (typically weeks, months or years) after receiving that information. This type of memory is typically dependent on gene transcription regulated by second messenger activation.

The process in which anatomical structures of the veins on an imaginal disc-derived wing are generated and organized.

Any process by which an organism or tissue maintains a population of germ-line stem cells.

Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.

Any process that stops, prevents, or reduces the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity.

The process in which a specialized cell loses the structural or functional features that characterize it in the mature organism, or some other relatively stable phase of the organism's life history. Under certain conditions, these cells can revert back to the features of the stem cells that were their ancestors.

Any process that stops, prevents, or reduces the frequency, rate or extent of R7cell differentiation.

Any process that stops, prevents, or reduces the frequency, rate or extent of the sevenless signaling pathway.

Any process that modulates the frequency, rate or extent of the JAK-STAT signaling pathway.

Any process that stops, prevents, or reduces the frequency, rate or extent of the JAK-STAT signaling pathway activity.

Any process that stops, prevents, or reduces the frequency, rate or extent of the JAK-STAT signaling pathway activity.

Establishment of a pattern of pigment in the compound eye.

The process in which the anatomical structures of the dorsal part of the body are generated and organized.

Any process that stops, prevents, or reduces the frequency, rate or extent of EGF-activated receptor activity.

Any process that stops, prevents, or reduces the frequency, rate or extent of EGF-activated receptor activity.

Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction.

The process in which a cell irreversibly increases in size over time by accretion and biosynthetic production of matter similar to that already present.

A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.

Any process in which STAT proteins (Signal Transducers and Activators of Transcription) and JAK (Janus Activated Kinase) proteins convey a signal to trigger a change in the activity or state of a cell. The JAK-STAT cascade begins with activation of STAT proteins by members of the JAK family of tyrosine kinases, proceeds through dimerization and subsequent nuclear translocation of STAT proteins, and ends with regulation of target gene expression by STAT proteins.

A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.

Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.

Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.

The process of covalently altering one or more amino acids in a protein after the protein has been completely translated and released from the ribosome.

Any process that activates or increases the frequency, rate or extent of T-helper 1 cell differentiation.

Any process that activates or increases the frequency, rate or extent of T-helper 1 cell differentiation.

Any process that stops, prevents, or reduces the frequency, rate or extent of T-helper 2 cell differentiation.

Any process that stops, prevents, or reduces the frequency, rate or extent of T-helper 2 cell differentiation.

Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a low-density lipoprotein particle stimulus.

Any process that stops, prevents, or reduces the frequency, rate, or extent of production of monocyte chemotactic protein-1.

Any response to fluid shear stress in a vascular endothelial cell.

Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell activation.

All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.